ShanX Medtech raises €24M to commercialise Ultra-Fast Antibiotic Resistance Testing
ShanX Medtech, an Eindhoven-based MedTech company developing next-generation diagnostics for antimicrobial susceptibility testing, has secured €24 million in Seed financing to move its technology toward market launch.

The best Articles in our Network